InMed Pharmaceuticals, Inc. (INM)
1.29
+0.04
(+3.20%)
USD |
NASDAQ |
Jan 09, 16:00
1.30
+0.01
(+0.78%)
After-Hours: 20:00
InMed Pharmaceuticals Market Cap: 3.617M for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 104.13M |
| Aurinia Pharmaceuticals, Inc. | 1.997B |
| Edesa Biotech, Inc. | 10.54M |
| Lexaria Bioscience Corp. | 18.57M |
| Xenon Pharmaceuticals, Inc. | 3.257B |
Market Cap Related Metrics
| PS Ratio | 0.5215 |
| Price to Book Value | 0.3121 |
| Price | 1.29 |
| Earnings Yield | -535.6% |